Lemonade Posts Q1 Beat as AI Push Lifts Revenue Outlook
NEW YORK, April 30 —
Lemonade filed an 8-K on April 29 disclosing Q1 results that, by most accounts, beat revenue expectations and pushed management to raise guidance. The coverage was glowing on the AI angle and split on the price action: some outlets logged a 6-7% pop, others marked an intraday drop as steep as 13%. Underneath the noise, the insider ledger tells a quieter story — net selling, with the CEO out the door at $99 in January.
- Q1 8-K filed April 29 under Items 2.02 and 9.01, with news coverage citing a revenue beat and raised guidance attributed in part to Lemonade's AI model.
- Insider activity over the last 90 days: $0 in purchases, $1.30M in open-market sales — including CEO Daniel Schreiber's 9,108-share sale at $99.04 on January 23 for $902,056.
- Trailing revenue of $0.74 billion grew 53.5% with a 53.0% gross margin and $115M in trailing free cash flow, against a market cap of roughly $4.30 billion.
The Print That Cut Both Ways
Earnings days for Lemonade have always been theatrical, and this one was no exception. Seeking Alpha, GuruFocus, and ChartMill led with shares jumping 6-7% on the beat. Motley Fool and MarketBeat watched the same tape and saw a 13% and 6.7% drop respectively. Both sets of headlines went up the same day. That kind of split usually means one of two things: either the print landed mid-session and the narrative got recut on the fly, or the buy-side and the headline writers were grading on different rubrics.
The shared facts are these. Revenue cleared consensus. Management raised the full-year outlook. Reporters credited the AI underwriting and claims pipeline that has been Lemonade's pitch since its 2020 IPO. None of which settles the question of whether the stock should be at $56 or somewhere else.
The Insider Tape
The 90-day picture before the print was unambiguous: zero open-market purchases against $1.30M in sales. The headline transaction was Schreiber's January 23 sale of 9,108 shares at $99.04 — a $902,056 ticket at a price meaningfully above where the stock trades today. CFO Timothy Bixby sold 2,135 shares at $50.12 on March 3 for roughly $107,000. Chief Insurance Officer John Sheldon Peters sold 1,773 shares the same day at $50.12, then came back the next session and sold another 3,571 at $52.50, totaling about $276,000 across two days.
The pattern matters less for the dollar amounts — these are not Carvana-scale liquidations — than for the direction. Five different insiders selling on five different dates, with no offsetting purchases, is the kind of footprint that suggests rule-based diversification rather than conviction. Schreiber's January exit at near triple the March prices is the eye-catcher.
The Pay Package
On March 18, the board granted equity awards of 820,000 and 180,000 shares each to Schreiber and President Shai Wininger. The grants were filed across multiple Form 4s the same day. The size is worth flagging in context: Lemonade also filed its definitive proxy on April 22, alongside additional soliciting materials — the routine disclosure cadence ahead of the annual meeting. Whatever the open-market sales signal, the equity awards say the board is still betting on the same two people at the top.
Growth Without Profit, Still
The fundamentals are the cleanest part of the story. Trailing revenue of $0.74 billion is up 53.5% — the kind of growth rate that disappeared from most insurance comps a decade ago. Gross margin sits at 53.0%, healthy for an insurer that prices through software. Free cash flow turned positive at $115 million on a trailing basis, which is the milestone Lemonade has been chasing since the IPO.
What the company has not yet delivered is GAAP profit. Forward P/E is -155.6x, which is not a multiple so much as a notation that the model still expects losses. The four most recent quarterly EPS prints came in at -$0.60, -$0.51, and -$0.29 — each one beating consensus (-$0.80, -$0.70, and -$0.39 respectively), but each one still negative. Lemonade has built a habit of clearing a low bar. The bar itself has not yet moved above zero.
What to Watch
The next checkpoints are mechanical. Whether the raised guidance survives Q2's loss-ratio data. Whether the insider ledger flips — a single open-market purchase from any C-suite name would change the optics quickly. Whether the analyst price target of $65.11 drifts up or down as the sell-side digests the print. And whether the stock can hold the post-earnings range, given that the same day produced both a 7% rally and a 13% drop depending on who was watching.
For readers building their own view of where Lemonade fits in a portfolio, the underlying mechanics — unit economics, loss ratios, AI productivity claims — are worth a deeper look than any single headline cycle provides.
Run the free Lemonade, Inc. deep-dive →
Basis Report does not hold positions in securities discussed. This is not investment advice.
Frequently Asked Questions
Did Lemonade beat Q1 2026 earnings?
Per the 8-K filed April 29, news coverage reported Lemonade beat Q1 revenue expectations and raised guidance, with the strength attributed in part to its AI-driven model, as detailed above.
Why did LMND stock fall after earnings?
Coverage was split — some outlets reported a 6-7% rally while Motley Fool and MarketBeat cited intraday declines of 13% and 6.7%. The article above breaks down the divergence.
Are Lemonade insiders selling stock?
Yes. Over the last 90 days, insiders sold $1.30M with zero open-market purchases, including a $902,056 sale by CEO Daniel Schreiber in January, per the Form 4 analysis above.
Is Lemonade profitable yet?
No on GAAP. Forward P/E is -155.6x and the four most recent quarterly EPS prints were negative, though trailing free cash flow reached $115M. See the fundamentals breakdown in the report.
What is Lemonade's current market cap and price target?
Lemonade's market cap is approximately $4.30 billion at $56 per share, with an analyst price target of $65.11, as referenced in the report above.